Howard University College of Medicine, Washington, DC 20060, USA.
J Natl Med Assoc. 2011 Sep-Oct;103(9-10):907-16. doi: 10.1016/s0027-9684(15)30446-6.
C-peptide blood levels can indicate whether or not a person is producing insulin and roughly how much. C-peptide is secreted as a byproduct of the biosynthesis of insulin from proinsulin. C-peptide has proposed biological activity and a well-established diagnostic value. The significance of C-peptide concentration in the plasma and urine in the pediatric population needs further delineation.
To determine the significance of plasma C-peptide in obese African American adolescents with mild insulin resistance but no evidence of diabetes.
This study included 19 African American adolescents with body mass index (BMI) in at least the 85th percentile evaluated with anthropometric measurements, Homeostatic Model Assessment-Insulin Resistance (HOMA-IR) score, and oral glucose tolerance test (OGTT), and 24-hour urine collections. The study also included an age-matched control group of 15 healthy African American adolescent controls and were not subjected for OGTT. The correlation among BMI, fasting plasma C-peptide concentrations, and 24-hour-urine C-peptide concentrations was calculated. T Tests were conducted to compare plasma C-peptide and 24-hour-urine C-peptide concentrations for the test group and controls.
Mean HOMA score (3.96 +/- 1.84) signified mild insulin resistance among the adolescent test group. The test subjects exhibited adequate glucose tolerance (glucose range, 89.4-122.5 mg/dL) during the OGTT. A significant positive relationship was observed between BMI and fasting plasma C-peptide concentration in the control group (r = 0.537) but not the test group (r = 0.335). An insignificant positive relationship was exhibited between BMI and 24-hour-urine C-peptide concentration in the test group (r = 0.150) and controls (r = 0.254).
The positive relationship among BMI, plasma C-peptide, and urine C-peptide is worth further evaluation in studies conducting multiple rounds of OGTT with a larger sample of pediatric subjects. The potential diagnostic value of C-peptide may facilitate early detection of insulin resistance in the pediatric population.
C-肽血液水平可以表明一个人是否在产生胰岛素,以及产生的胰岛素量大致是多少。C-肽是胰岛素原生物合成过程中作为副产物分泌出来的。C-肽具有提出的生物学活性和既定的诊断价值。在儿科人群中,血浆和尿液中的 C-肽浓度的意义需要进一步阐明。
确定肥胖非裔美国青少年中血浆 C-肽的意义,这些青少年存在轻度胰岛素抵抗,但没有糖尿病的证据。
这项研究纳入了 19 名非裔美国青少年,他们的体重指数(BMI)至少在第 85 百分位,通过人体测量学测量、稳态模型评估-胰岛素抵抗(HOMA-IR)评分和口服葡萄糖耐量试验(OGTT)以及 24 小时尿液收集进行评估。该研究还纳入了年龄匹配的 15 名健康非裔美国青少年对照组,他们没有接受 OGTT。计算了 BMI、空腹血浆 C-肽浓度和 24 小时尿液 C-肽浓度之间的相关性。对实验组和对照组的血浆 C-肽和 24 小时尿液 C-肽浓度进行 T 检验。
青少年实验组的平均 HOMA 评分(3.96 +/- 1.84)表明存在轻度胰岛素抵抗。在 OGTT 中,实验组的葡萄糖耐量正常(葡萄糖范围 89.4-122.5mg/dL)。在对照组中,BMI 与空腹血浆 C-肽浓度之间存在显著的正相关关系(r=0.537),但在实验组中不存在(r=0.335)。在实验组(r=0.150)和对照组(r=0.254)中,BMI 与 24 小时尿液 C-肽浓度之间也存在不显著的正相关关系。
BMI、血浆 C-肽和尿液 C-肽之间的正相关关系值得在对具有更大儿科样本的研究中进行多次 OGTT 进一步评估。C-肽的潜在诊断价值可能有助于在儿科人群中早期发现胰岛素抵抗。